4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-21-000005
Chief Operating Officer sold 45,049 shares at an average $12.03 ($541,719)
- Chief Operating Officer acquired 77,624 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shea Jacqueline Elizabeth · Chief Operating Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 1 in the form | +22,376 | $3.62 | $81,001 | 34,296 | D |
| 2021-01-27 | Sale : show line 2 in the form | −22,376 | $12.01 | $268,736 | 11,920 | D |
| 2021-01-27 | Sale : show line 3 in the form | −5,960 | $12.04 | $71,758 | 5,960 | D |
| 2021-01-28 | Exercise or conversion : show line 4 in the form | +55,248 | $3.62 | $199,998 | 61,208 | D |
| 2021-01-28 | Sale : show line 5 in the form | −16,713 | $12.04 | $201,225 | 44,495 | D |
| Open-market sales · 45,049 sh · avg $12.03 · $541,719 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 6 in the form Common Stock Option | −22,376 | 177,624 | D |
| 2021-01-28 | Exercise or conversion : show line 7 in the form Common Stock Option | −55,248 | 122,376 | D |
Loading xslF345X03/wf-form4_161196497789987.xml…